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Rickettsia rickettsii, the etiologic agent of Rocky Mountain spotted fever, purified from infected L-929 cells
by density gradient banding were extrinsically radioiodinated with lactoperoxidase. Immunodominant
1251-labeled antigens were identified by radioimmunoprecipitation of detergent-solubilized antigens with
protein A-Sepharose and anti-R. rickeusii sera collected 0, 3, 7, 11, 32, and 163 days after infection of guinea
pigs. The average fever .400C was detected by days 3 and 4 after infection with 6 X 107 and 6 x 106 PFU,
respectively. By microagglutination and complement fixation assays, anti-R. ricketfsii antibodies were detected
as early as day 3 after infection, with titers increasing markedly between days 7 and 163. Convalescent sera,
collected on day 163, from infected guinea pigs were used to identify seven 125I-labeled antigens with apparent
molecular sizes of 186,000 (I), 145,000 (II), 49,000 (III), 32,000 (IV), 27,500 (V), 17,500 (VI), and 16,500 (VII)
daltons. Differences in antibody reactivity and specificity against the seven antigens were demonstrated with
serially obtained sera. Sera from a guinea pig infected with 6 x 107 PFU exhibited antibody-antigen
interactions with all seven 125I-labeled antigens by day 7, whereas the same antibody activity required 32 days
for an animal infected with 6 x 106 PFU. Prominent antibody activities toward proteins II and IV were
demonstrated both early and late after infection. The fluids obtained from infected L-929 cells contained three
soluble antigens which were detected with the 11-, 32-, and 163-day sera by an immunodiffusion assay. The
soluble and 125I-labeled antigens of R. rickettsii identified in this study may be important candidates for vaccines
against Rocky Mountain spotted fever.
Rickettsia rickettsii, the etiologic agent of Rocky Moun-
tain spotted fever (RMSF), is an obligately intracytoplasmic
pathogen of eukaryotic cells. RMSF is a life-threatening,
tickborne rickettsiosis with an annual morbidity in the
United States of approximately 1,100 persons (11). Three
vaccines against RMSF have been developed, but none has
provided satisfactory protective immunity. R. rickettsii in-
activated with Formalin was observed in (i) the infected tick
tissue vaccine that was used in the 1920s and 1930s (27), (ii)
the infected chicken yolk sac vaccine that was withdrawn
from public use in the early 1970s (7), and (iii) the infected
cell culture vaccine (4, 13) that was never released for public
use. All three vaccines failed to adequately protect human
volunteers who were challenged with virulent R. rickettsii (6,
8). Because the antigens of R. rickettsii necessary to stimu-
late protective immunity against RMSF were not identified,
their presence and concentration in these vaccines were not
determined.
The cell wall of R. rickettsii is composed of outer mem-
brane, peptidoglycan, and cytoplasmic membrane (25).
Outer membrane protein and polysaccharide antigens of R.
rickettsii have been demonstrated (3, 12, 26), but their roles
in active immunity have not been established. Recently, the
cellular location of one of these antigens has been studied by
Triton X-100 extraction of antigens (2) and immunoprecipi-
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tation of surface-labeled protein antigens (3). The kinetics of
the humoral immune response to specific surface antigens of
R. rickettsii after infection have not been adequately studied
so that soluble antigens and cell-associated outer membrane
antigens can be identified. In our study, we identified soluble
antigens and cell-associated antigens of R. rickettsii that
react with serum antibodies of experimentally infected
guinea pigs. The soluble and surface-expressed antigens of
R. rickettsii identified in this study may be important candi-
dates for vaccines against RMSF.
MATERIALS AND METHODS
Rickettsial strain. R. rickettsii (Sheila Smith strain) was
grown in yolk sacs of chicken eggs (28). The 50% yolk sac
suspensions (wt/vol, grams of yolk sac per milliliter of brain
heart infusion) were prepared and stored at -70°C. The
inocula used in this study contained 3 x 108 PFU per ml of
yolk sac seed (19).
Guinea pig anit-R. rickettsii sera and serology. Female
Hartley strain guinea pigs (12) weighing approximately 300 g
each (raised at the Rocky Mountain Laboratories, Hamilton,
Mont.) were pre-bled, divided into two equal groups, and
then infected by intraperitoneal inoculation of 6 x 106 or 6 x
107 PFU of R. rickettsii. Rectal temperatures were measured
for 12 consecutive days, and specific serum antibody to R.
rickettsii was monitored on days 0, 3, 7, 11, 32, and 163,
respectively (Fig. 1A and B). Sera collected from guinea pigs
1 and 2 were used in immunoprecipitation experiments with
six serial serum samples from each guinea pig. Antibody
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FIG. 1. Temporal sequence offever and antibody responses in R. rickettsii-infected guinea pigs. Animals were inoculated intraperitoneally
with 6 x 107 PFU (guinea pig 1) or 6 x 106 PFU (guinea pig 2). Serum antibody titers were determined with the MA and CF assays. The
163-day titers represent sera from surviving animals that were given an intraperitoneal booster inoculation of 10 ,ug of Formalin-killed R.
rickettsii 11 days earlier.
titers were determined by the microagglutination (MA) (10)
and complement fixation (CF) (5) assays.
Growth of R. rickeffsii in L-929 cells. There were 10 flasks
(75 cm2, Corning Glass Works, Corning, N.Y.) inoculated
with 107 L-929 cells in 2Q ml of medium 199 (GIBCO
Laboratories, Grand Island, N.Y.) containing 5% fetal calf
serum and no antibiotics. After 24 h, the confluent monolay-
ers were infected with R. rickettsii by adding 3 x 105 PFU in
1 ml of brain heart infusion to the cell monolayer. R.
rickettsii were allowed to adsorb to the L-929 cells for 30 min
at room temperature by using a rocker platform (Rocker
Platform; Bellco Glass, Inc., Vineland, N.J.) to maintain
consistent fluid distribution. Then 19 ml of fresh medium 199
containing 5% fetal calf serum was added and incubated in a
5% CO2 atmosphere at 35°C. After 24 h of incubation,
cycloheximide was added to a final concentration of 0.5
,ug/ml of prevent host cell protein synthesis. This concentra-
tion was nontoxic for the L-929 cells, and it allowed good
growth of rickettsiae. Infected cell culture monolayers were
harvested on day 7 postinfection.
Separation of R. ricketsii from infected L cells. Infected L
cells were removed from the plastic surface by adding 1 g of
sterile glass beads (3 to 5 mm in diameter) followed by
shaking. The suspension of cells and R. rickettsii was
removed from the flasks with cannula and syringe and placed
in a 500-ml centrifuge bottle. The glass beads and flask were
washed with 20 ml of brain heart infusion and pooled with
the first suspension. This suspension was centrifuged at
12,000 x g for 30 min in a fixed-angle rotor. Supernatant (Si)
fluids were saved and analyzed for soluble antigens by
immunodiffusion (18). Pellets were suspended in 0.5 ml of
brain heart infusion per initial tissue culture flask. This
suspension was layered on a solution of 7.6% Renografin
(E. R. Squibb & Sons, Princeton, N.J.) and 25% sucrose
prepared in K36 buffer (36) and centrifuged on a horizontal
rotor at 12,000 x g for 45 min. Pellets were suspended in 15
ml of phosphate-buffered saline containing 0.25 M sucrose
(38). A portion (5 ml) of this suspension was layered over
each of three continuous Renografin gradients (20 to 45%)
(35). Centrifugation was performed at 85,000 x g for 60 min.
The band of R. rickettsii was withdrawn from the gradient
with a cannula and syringe, diluted with phosphate-buffered
saline containing 0.25 M surcrose, and collected by centrif-
ugation at 12,000 x g for 20 min. Pellets were suspended in
5 ml of phosphate-buffered saline containing 0.25 M sucrose,
and the organisms were quantitated spectrophotometrically
at 450 nm by using a standard curve similar to that reported
for Coxiella burnetii (38). Approximately 40 ,ug of R. rick-
ettsii cells was recovered per flask. These freshly purified
cells were surface-labeled with 1251 and lactoperoxidase (see
below) after examining their morphologic features by direct
immunofluorescence (23).
Lactoperoxidase-catalyzed 125I-labeling of purified R. ricket-
tsii. Freshly purified R. rickettsii whole cells (400 ,ug) (see
above) were radiolabeled with lactoperoxidase and Na'251 as
previously described for C. burnetii (37).
Extraction of '25I-labeled surface protein. The 125I-labeled
cells (400 ,ug) were suspended in 0.5 ml of lysing buffer
containing 0.02 M Tris hydrochloride in 0.85% saline (pH
7.4), 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic
acid, and 0.5% Triton X-100 (3, 39). The suspension was
incubated at 37°C for 4 h and then centrifuged at 100,000 x
g for 1 h. The supernatant was saved, and the pellet was
washed twice with 0.5 ml of lysing buffer. Pooled superna-
tant fluids (1.5 ml) were used in radioimmunoprecipitation
(RIP) experiments.
RIP assay. RIP of detergent-solubilized 125I-labeled R.
rickettsii antigens was carried out at room temperature
(approximately 23°C) with both protein A-Sepharose (PAS)
(CL-4B; Pharmacia Fine Chemicals, Piscataway, N.J.) and
Staphylococcus aureus Cowan I (SACI) obtained from Jim
Collins, Rocky Mountain Laboratories. SACI was prepared
by the procedure of Kessler (14) and used as a 10% suspen-
sion in NET buffer prepared as follows: 0.05 M Tris hydro-
chloride (pH 7.4) in 0.85% saline, 0.5% Triton X-100, 0.005
M EDTA, and 0.02% NaN3. PAS was rehydrated overnight
at 4°C in NET buffer before use. The final concentration of
protein A was 21 ,ug/100 ,ul of suspended PAS.
RIP of 125I-labeled antigen-antibody complexes was per-
formed as follows. (i) 125I-labeled soluble antigen (25 ,ul) was
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TABLE 1. Temporal sequence of fever and antibody responses in R. rickettsii-infected guinea pigs
Inoculum size Avg value after infection on dayb:
(PFU) and
parametera 0 3 4 5 6 7 8 9 10 11 12 32 163
106
Temp 39.3 39.1 40.0 40.5 40.3 40.0 39.8 39.5 39.4 39.5 39.4 39.5 39.5
CF <8.0 8.0 NDC ND ND 50.8 ND ND ND 1,290 ND 3,250 5,790
MA <2.0 10.1 ND ND ND 20.2 ND ND ND 40.3 ND 323 645
107
Temp 39.3 40.4 40.9 40.6 40.5 40.1 39.7 39.7 39.6 39.6 39.5 39.6 39.6
CF <8.0 9.0 ND ND ND 114.0 ND ND ND 2,900 ND 2,580 5,810
MA <2.0 2.8 ND ND ND 40.3 ND ND ND 90.5 ND 181 645
a See Materials and Methods for details. Antibody levels were determined by the CF and MA assays. Values are reported as the geometric mean for six guinea
pigs per group. Rectal temperature (Temp) of the guinea pigs were measured, and the standard error was ± 0.1 for both the 6 x 106 and 6 x 107 PFU dosages.
b Measurements and samples were collected throughout a 163-day period.
c ND, Not done.
added to either 50 ,1u of buffer, normal guinea pig sera,
guinea pig anti-R. rickettsii sera, or guinea pig anti-C.
burnetii sera (38) prepared by infecting animals with 105 PFU
obtained from a 50% yolk sac seed and then by hyperim-
munizing the same animals 30 days later with Formalin-
killed phase I C. burnetii. The suspensions were incubated
for 30 min at 25°C in 1.5-ml tubes with occasional mixing. (ii)
Then 100 ,ug of either PAS or SACI was added, and the
suspension was incubated for 30 min at 25°C. NET buffer (1
ml) was added, and the insoluble material was sedimented by
centrifugation for 3 min in a Microfuge B (Beckman Instru-
ments, Inc., Fullerton, Calif.). The supernatant was care-
fully aspirated, and the pellet was washed twice with 1.0-ml
volumes of NET buffer. (iii) The final pellet was suspended
in 100 ,ul of Laemmli sample buffer (15), and the suspension
was boiled for 3 min. The slurry (40 RI) was applied to
preformed slots in a 5% acrylamide stacking gel (15). SDS-
polyacrylamide gel (PAG) electrophoresis was carried out at
40 mA of constant current until the tracking dye had mi-
grated 25 cm into the 12.5% acrylamide-separating gel slab.
The PAG slab was fixed overnight in a 40% ethanol-5%
acetic acid solution (vol/vol), washed 5 min in water, and
placed in a 3% glycerol solution for 30 min with a piece of
3MM filter paper (Whatman, Inc., Clifton, N.J.) cut to
exceed the PAG slab dimension in both directions. The PAG
slab was placed on the filter paper during transfer to the slab
gel dryer (Model 224; Bio-Rad Laboratories, Richmond,
Calif.). The dried PAG slab was placed directly against
X-ray film (XAR-5; Eastman Kodak Co., Rochester, N.Y.)
for exposure with an intensifying screen (Dupont Cronex
Lightning-Plus BJ; E. I. du Pont de Nemours & Co., Inc.,
Wilmington, Del.) at -70°C. Autoradiograms were analyzed
both by visual inspection and by scanning on a Joyce-Loebl
microdensitometer equipped with an integrating attachment.
Inactivation of soluble antigens by NaOH. Protein antigens
in the tissue culture fluids were hydrolyzed in a boiling
solution (98°C) of 0.2 N NaOH for 30 min (18). The solution
was neutralized with Veronal buffer (20). Immunodiffusion
assays were done with 1% agarose gels and Veronal buffer
(20).
RESULTS
R. rickettsii infection of guinea pigs. Temperatures of in-
fected guinea pigs were measured consecutively for 12 days,
and anti-R. rickettsii antibody titers were measured on days
0, 3, 7, 11, 32, and 163. The average rectal temperatures and
anti-R. rickettsii responses of the infected guinea pigs are
presented in Table 1. Although six guinea pigs were used in
each group, only the results from guinea pigs 1 and 2 are
presented in Fig. 1. The two dosages of R. rickettsii were
chosen to demonstrate the differences in elicitation of anti-
body activity toward 125I-labeled antigens. Temperatures
.40.00C were observed on day 6 after 6 x 107 PFU (guinea
pig 1) and on day 8 after 6 x 106 PFU (guinea pig 2) of R.
rickettsii was inoculated, respectively (Fig. 1A). Antibody
responses to antigens of R. rickettsii were measured by the
MA and CF assays on days 0, 3, 7, 11, and 32 after infection
and are presented in Fig. 1B along with the antibody
response on day 163 after a booster inoculation 11 days
earlier with 10 ,ug of Formalin-killed R. rickettsii. Antibody
titers were detected on day 3 postinfection, with titers
increasing markedly between days 7 and 32. Antibody titers
after the booster inoculation were similar to the 32-day
value.
RIP with SACI and PAS. SACI has been used extensively
to precipitate antigen-antibody complexes through the inter-
action of the Fc portion of certain immunoglobulin mole-
cules and protein A. The use of PAS as a more specific
antibody absorbent has resolved some of the problems
associated with the SACI reagent. SACI and PAS ad-
sorbents were compared for relative specificity of the anti-
body-dependent precipitation reactions. The addition of
normal guinea pig or anti-C. burnetti sera to the reaction
mixture containing SACI and 1251-labeled components
caused precipitation of several very similarly distributed
'25I-labeled components (Fig. 2A and B, lanes 2 and 3).
These apparently antibody-independent interactions were
not observed when PAS was substituted for SACI in the
reaction mixture (Fig. 2C and D, lanes 2 and 3). Antibody-
dependent precipitation was observed when anti-R. rickettsii
serum was added to the reaction mixtures containing SACI
or PAS and 125I-labeled components (Fig. 2A and B, lane 4).
The seven 125I-labeled bands were more clearly observed
with the PAS reagent (Fig. 2C, lane 4, and Fig. 3A through
F). Densitometric tracings of autoradiograms (Fig. 2D, lane
4) show the major bands I through VII, ranging in molecular
size from 186 to 16.5 kilodaltons (186K to 16.5K, respec-
tively). Interestingly, the 17.5K and 16.5K components
showed some affinity for the SACI and PAS reagent regard-
less of the NET buffer or serum substitution in the reaction
mixture.
RIP of surface protein with serially collected sera. In this
study, we were interested in R. rickettsii proteins which
elicited early and late antibody responses. We did not
examine whole cell profiles of 125I-labeled constituents,
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FIG. 2. Comparison of precipitation reactions with SACI and PAS as adsorbents. 1251-surface-labeled R. rickettsii were lysed, and the
100,000 x g supematant fluid was used to test nonspecific and antibody-specific precipitation of 251I-labeled proteins. SACI (panels A and B)
and PAS (panels C and D) were tested as adsorbents in various reaction mixtures containing 100 of '251-labeled protein antigens and 50 ,u1
of (1) NET buffer, (2) normal guinea pig serum, (3) guinea pig anti-C. burnetii serum, or (4) guinea pig anti-R. rickettsii serum. Autoradiograms
of dried SDS-PAGs were developed after a 3-day exposure to Kodak XAR-5 X-ray film with a DuPont Cronex Lightning-Plus BJ screen.
Densitometric tracings of autoradiograms are shown in SACI (B) and PAS (D). With NET buffer (lane 1) nonspecific precipitation was not
observed. With normal serum and anti-C. burnetii serum (lanes 2 and 3) nonspecific precipitation was significant with only SACI. Seven major
bands ranging in molecular weights (MW) from 186K to 16.5K (I through VII) were detected with PAS and anti-R. rickettsii serum (lane 3).
solubilized components, or Coomassie-stainable proteins. In
another study, Anacker et al. (3) observed Coomassie bril-
liant blue and silver-stained bands in regions of the SDS-
PAG which could be representative of the 125I-labeled anti-
gens in our study.
Sera serially collected from R. rickettsii-infected guinea
pigs demonstrated the kinetics of the antibody response to
the surface-exposed antigens of R. rickettsii. Data from
immunoprecipitation with PAS, 125I-labeled surface pro-
teins, and only two animal sera (guinea pigs 1 and 2) are
compared in Fig. 3. Densitometric tracings of autoradio-
grams exposed to the dried slab gel for 10 h (Fig. 3A and D),
5 days (B and E), and 14 days. (C and F) are compared.
Immunoprecipitation with serum from guinea pig 1 (Fig. 3A)
and a 10-h exposure revealed two (II and IV) and three bands
(II, III, and IV) for the 32- and 163-day serum samples,
respectively. Longer exposures revealed seven bands and
indicated that antibodies directed at bands II and IV were
detected by day 11 postinfection.
The two sera (Fig. 3A and D) were not identical with
respect to the early antibody response and the number of
surface antigens recognized at 32 days postinfection. Immu-
noprecipitation with serum from guinea pig 2 and the 10-h
exposure revealed two (II and IV) and six bands (I to IV, VI,
and VII) for the 11- and 32-day sera samples, respectively.
Longer exposures revealed at least seven bands with the
32-day sera. Also, nonspecific precipitation of bands VI and
VII with the preimmune serum was apparent; however, the
activity in these two bands was increased after infection
(Fig. 3D, E, and F), with the 7- and 11-day sera showing
progessively greater activity. Day 7 immune serum antibod-
ies detected bands II, III, IV, VI, and VII.
Soluble antigens of R. rickettsii. Supernatant fluids S1








124 WILLIAMS ET AL.
A



















30 46 f9 )\ 200
92.5 100
(-)
FIG. 3. Immunoprecipitation reactions with PAS, l25l-labeled surface proteins, and guinea pig sera. Sera were collected serially at 0, 3,
7, 11, 32, and 163 days after infection with 6 x 106 (panels A, B, and C) and 6 x 107 (panels D, E, and F) PFU of R. rickettsii. Autoradiograms
of dried SDS-PAGs were developed after exposure for 10 h (panels A and D), 5 days (panels B and E), and 14 days (panels C and F).
Densitometric tracings of autoradiograms are shown. Note that with increased exposure time more bands were detected. In panels D, E, and
F the 163-day serum sample was not tested. Symbols: I, top of the SDS-PAGs where an antigen was detected; *, additional bands were
detected with this serum.
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FIG. 4. Detection of soluble antigens of R. rickettsii in an immu-
nodiffusion assay. Tissue culture fluids of infected L-929 cells were
collected, concentrated 10-fold, and analyzed for antigens by using
hyperimmune 163-day serum from R. rickettsii-infected guinea pigs.
Labels: 1, L-929 cell culture fluid; 2, hyperimmune 163-day serum;
a, b, and c, precipitate lines of antigen-antibody interactions.
disrupted infected L cells were subjected to immunodiffu-
sion analysis (20) by using the 163-day anti-R. rickettsii
serum of guinea pig 2. Three lines of precipitation were
observed with the 163-day immune sera (Fig. 4a, b, and c).
Precipitation arcs also were observed with the 11- and
32-day sera (not shown). Hydrolysis of protein antigens was
accomplished by treating the Si fluid with 0.2 N NaOH for
30 min at 98°C (18). Immunodiffusion analysis after NaOH
treatment of the S1 fluid yielded only one precipitate arc (not
shown), suggesting that one of the three soluble antigens was
a polysaccharide antigen (18) and perhaps a lipopolysaccha-
ride antigen (3). The relationship between these soluble
antigens and the '251-labeled antigens has not been studied.
DISCUSSION
In this investigation we identified seven cell-associated R.
rickettsii protein antigens which were radiolabeled with
lactoperoxidase and which stimulated a humoral immune
response during experimental infection of guinea pigs. Al-
though many proteins of R. rickettsii have been demon-
strated by SDS-PAG electrophoresis (9, 17, 21, 31), their
cellular locations, ability to stimulate an immune response,
and functions are not known. The recent demonstration of
proteins extracted with Triton X-100 (2) and present on the
surface of purified R. rickettsii (3) are beginning steps toward
the elucidation of the important protein antigens of R.
rickettsii. Antiserum to the protein antigen extracted with
Triton X-100 was efficacious in guinea pigs and mice by two
biological assays. (i) The fever response was reduced in
guinea pigs inoculated with a mixture of antiserum and
rickettsiae when compared with controls, and (ii) mice were
protected against the lethal effects of an intravenous chal-
lenge with 2 50% lethal doses of R. rickettsii (2). The seven
rickettsial protein antigens identified in our study are impor-
tant candidates for the stimulation of protective immunity
because of their probable surface location. Elicitation of an
antibody response by these protein antigens suggests that
they are immunogenic and vulnerable to effective action by
host cellular immune and phagocytic systems. These im-
mune mechanisms should be very effective against the
extracellular rickettsiae before penetration of the subsequent
host cell.
Others have demonstrated that protein antigens of R.
rickettsii are recognized by the humoral immune response of
humans, mice, and guinea pigs. Comparison of protein
antigens identified in our study with those of other studies
show many antigens with similar estimated molecular sizes
(1-3, 9, 11, 22, 32, 34). Recently, Anacker et al. (1) identified
murine monoclonal antibodies which reacted with antigens
of approximately 170K, 133K, and 32K. Antibodies reacting
with the 170K and 133K protein antigens protected mice
against challenge with R. rickettsii (1). The demonstration of
antibody response to protein antigens of 33K, 30K, 18K (34),
177K, and 133K (1) in sera from patients convalescing from
RMSF corresponds roughly to proteins I, II, IV, and VI.
In a previous study (3), attempts to demonstrate cell-
associated R. rickettsii antigens by RIP were complicated by
the fact that the rickettsiae used as an immunogen and the
251I-labeled rickettsiae were both from infected yolk sacs.
Although five antigens were apparently identified (3), none
of those antigens corresponded in molecular size to the
seven 125I-labeled antigens identified in our study. We used
antisera from guinea pigs infected with rickettsiae prepared
from yolk sac-grown rickettsiae and 125I-labeled antigens
from R. rickettsii-infected L-929 cells. R. rickettsii adsorb
host components which are difficult to remove by density
gradient banding. For this reason it is important to prepare
anti-R. rickettsii sera by using viable rickettsiae grown in a
eukaryotic cell which may not share cross-reacting determi-
nants with the host cell from which rickettsial antigens are
prepared. We did not detect cross-reactions of putative
L-cell antigens with yolk sac antigens in the R. rickettsii
fraction with guinea pig anti-C. burnetii sera prepared in a
similar fashion as the anti-R. rickettsii sera. Therefore, a
comparison of antigens identified in our study with other
reports is complicated by differences in technique and inher-
ent inaccuracies of attempted estimation of molecular size
over a broad range in a gel of a particular polyacrylamide
composition. Moreover, it is likely that there are one or
more labile proteins or soluble antigens that may be lost
during the purification of R. rickettsii whole cells and other
steps in the analysis.
We demonstrated that R. rickettsii-infected L-929 cells
elaborate at least three soluble antigens which were either
present in the tissue culture fluids or released from the
rickettsia and cytoplasm of infected eukaryotic cells after
shaking with glass beads. Hydrolysis of these antigens with'
NaOH indicated that at least one of the antigens (Fig. 4a, b,
or c) was representative of a polysaccharide or lipopolysac-
charide antigen. Lipopolysaccharide (or polysaccharide) an-
tigens were recently demonstrated in whole cell proteinase
K-treated extracts of R. rickettsii (3). Other studies have
identified a NaOH-insensitive erythrocyte-sensitizing sub-
stance (18). Our study represents the first attempt to identify
soluble antigens in the fluids generated during the purifica-
tion of R. rickettsii-infected L-929 cells.
The relationship between the 125I-labeled cell-associated
proteins and the three soluble antigens remains to be dem-
onstrated. Proof of their importance for protective immunity
requires purification of adequate quantities of these antigens
for their evaluation individually and combined in immuniza-
tion experiments of animals followed by virulent rickettsial
challenge. Ultimately, it will be interesting and possibly
necessary to determine the function of these antigens in
normal rickettsial physiology as well as their pathogenic
roles in injury to the host cell. From our results it is clear that
soluble antigens may be elaborated during the infection of
eukaryotic cells. This leads one to think that soluble antigens
may be identified on the surfaces of the infected L-929 cells.
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If this is the case, these antigens may be important immu-
nogens to be considered for the development of new vac-
cines since whole cells have been shown to be ineffective as
vaccines.
The demonstration that T-lymphocyte immunity is medi-
ated by gamma interferon raises important questions about
rickettsial diseases (16, 24, 29, 30, 31, 33, 40). (i) Which
antigens are most important in stimulating the afferent arm of
the cell-mediated immune response? (ii) Which antigens are
exposed to cells capable of secreting gamma interferon in the
vicinity of endothelial and vascular smooth muscle cells
containing intracellular R. rickettsii? (iii) How effective are
antibodies to specific surface or soluble antigens of R.
rickettsii in eliminating rickettsiae during the frequent extra-
cellularjourneys of the organisms after release from one host
cell until entry into another host cell?
Virulent strains of the RMSF group are widespread in the
environment, but virulence factors per se remain elusive.
Identification and characterization of antigens unique to
highly virulent strains of the spotted fever group might lead
to a more critical evaluation of virulence markers and
candidate vaccines.
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